Prostate Cancer Webinars
Prostate SBRT and the Pace-B Trial
Alison Tree, Consultant Clinical Oncologist MBBS, BSc, FRCR, M.D.(Res) | Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London
Intensity-Modulated Fractionated Radiotherapy versus Stereotactic Body Radiotherapy for Prostate Cancer (PACE-B): Acute Toxicity Findings from an International, Randomised, Open-Label, Phase 3, Non-Inferiority Trial
Nicholas van As, M.D. | Royal Marsden Hospital, London, UK
SBRT as a Salvage Option for Localized Recurrent Prostate Cancer
Donald Fuller, M.D. | Genesis Healthcare Partners, San Diego, CA, USA
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction
Michael Repka M.D. | Medstar Georgetown University Hospital, Washington, DC (Currently at NYU Langone Health, New York, NY, USA
Safe and Effective Stereotactic Body Radiation Therapy (SBRT) for High-Risk Prostate Cancer Patients: 4-year Outcomes of a Phase II Trial
Victor Macias Hernandez, M.D., Ph.D. | Salamanca University Hospital, Valladolid University Hospital, Spain
The CyberKnife® System
The CyberKnife System is commonly used to treat low- to intermediate-risk prostate cancer and is the only radiotherapy device supported by years of published clinical follow-up with a large number of patients.
These studies provide reassurance to patients and providers that excellent clinical results are reproducible at any CyberKnife center
A CyberKnife® Patient Story
Dr. Robert Meier and CyberKnife® patient Mike “Bing” Crosby take to the air to discuss CyberKnife System treatments for low- to intermediate-risk prostate cancer.
Real-World Clinical Support
Listen to the medical team at the Geisinger Cancer Care about their experience with the CyberKnife S7 System.
The TomoTherapy® and Radixact® Systems
An ideal clinical solution for routine and complex prostate cancer treatments.
Treating Prostate Cancer with the Radixact System and Synchrony®
Read how Synchrony enables personalized real-time adaptive delivery of radiation treatment with the Radixact System to targets while they are in motion by synchronizing the delivery beam position to the target location precisely and accurately during continuous delivery of a treatment fraction.
Treating Prostate Cancer with the TomoTherapy® System
Dr. Nadia Di Muzio of the OSR – San Raffaele Scientific Institute, Milan, Italy discusses the use of helical IG-IMRT to treat prostate cancer patients.